Pathos AI has secured $365 million in a series D raise as the artificial-intelligence-powered biotech looks to fund trials of ...

Biohaven is giving investors whiplash. Forty-eight hours after saying its filing was on track, the biopharma revealed the FDA ...

WASHINGTON — FDA Commissioner Martin Makary offered more details into the agency’s recently announced plans to place ...

The Garden State is looking to grow into the next big biotech hub. | The Garden State is looking to grow into the next big ...

Enliven Therapeutics has decided against taking its phase 1-stage solid tumor drug into further development next year in ...

In its yearly survey of international clinicians and patients, Philips illustrated significant gaps in people’s trust when it ...